Promoters confirm no new share encumbrances in FY26

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.7%1-day move

₹460.00

prior close

₹460.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.8+0.0-0.4-0.7-2.2-1.5-2.0-1.2-2.2-3.4-7.6——

Up moveDown movePending

AI summary

Berhyanda Limited, along with persons acting in concert (Jusmiral Holdings, Berhyanda Midco, Jusmiral Midco), promoters of Cohance Lifesciences, have filed a declaration under SEBI Takeover Regulations confirming they have not created any new encumbrance (pledge or lien) on the company shares during FY 2025-26, beyond what was already disclosed earlier. This is a routine annual disclosure under Regulation 31(4) to assure the market that promoters have not silently pledged more shares.

Likely market impact

No new share pledges by promoters. Routine filing - neutral for shareholders, reflects promoter transparency and no fresh encumbrance risk.